HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
50 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SQSTM1
sequestosome 1
Chromosome 5 Β· 5q35.3
NCBI Gene: 8878Ensembl: ENSG00000161011.21HGNC: HGNC:11280UniProt: Q13501
1,058PubMed Papers
4Diseases
0Drugs
57Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
RESEARCH IMPACT
Highly StudiedTrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
molecular sequestering activityprotein bindingubiquitin bindingK63-linked polyubiquitin modification-dependent protein bindingPaget disease of bone 3Frontotemporal dementia and/or amyotrophic lateral sclerosis 3Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onsetMyopathy, distal, with rimmed vacuoles
✦AI Summary

SQSTM1 (p62) is a multifunctional scaffolding protein that serves as a critical molecular adapter in selective autophagy processes 1. Its primary function involves bridging polyubiquitinated proteins and damaged organelles to autophagosomes for degradation through a process called aggrephagy 2. SQSTM1 operates through distinct molecular mechanisms: it first undergoes liquid-liquid phase separation upon binding ubiquitinated proteins via its UBA domain, forming cytoplasmic p62 bodies 2. Subsequently, it interacts with ATG8 family proteins (LC3A/B) on autophagosomes through its LIR motif, facilitating cargo recruitment and autophagic clearance 2. The protein is degraded along with its cargo during this process. SQSTM1 plays essential roles in mitophagy, where it mediates PINK1/Parkin-dependent clearance of damaged mitochondria by recruiting ubiquitinated VDAC1 to autophagosomes 3. Additionally, SQSTM1 phase separation can transform into P-bodies under stress conditions, which activate the NLRP3 inflammasome and induce inflammatory responses 4. Disease relevance includes associations with neurodegenerative disorders and inflammatory diseases. SQSTM1 dysfunction leads to accumulation of protein aggregates and impaired cellular homeostasis 56, making it a potential therapeutic target for autophagy-related pathologies.

Sources cited
1
SQSTM1 is a multifunctional scaffolding protein involved in selective autophagy and signaling pathway regulation
PMID: 30588824
2
SQSTM1 binds LC3 proteins and mediates degradation of ubiquitinated protein aggregates through autophagy
PMID: 17580304
3
SQSTM1 is essential for PINK1/Parkin-mediated mitophagy and clearance of damaged mitochondria
PMID: 20098416
4
SQSTM1 phase separation can form P-bodies that activate the NLRP3 inflammasome under stress conditions
PMID: 38460129
5
SQSTM1-mediated autophagic degradation is regulated by palmitoylation and affects inflammatory responses
PMID: 35066577
6
SQSTM1 participates in autophagy-lysosome pathway for degradation of specific proteins like FN1
PMID: 33318468
Disease Associationsβ“˜4
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3UniProt
Myopathy, distal, with rimmed vacuolesUniProt
Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onsetUniProt
Paget disease of bone 3UniProt
Pathogenic Variants57
NM_003900.5(SQSTM1):c.1210A>G (p.Met404Val)Pathogenic
Paget disease of bone 2, early-onset;Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|SQSTM1-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 404
NM_003900.5(SQSTM1):c.823_824del (p.Ser275fs)Pathogenic
not provided|See cases|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset
β˜…β˜…β˜†β˜†2025β†’ Residue 275
NM_003900.5(SQSTM1):c.526_529del (p.Ser176fs)Pathogenic
not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset
β˜…β˜…β˜†β˜†2025β†’ Residue 176
NM_003900.5(SQSTM1):c.301+1G>TPathogenic
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset|SQSTM1-related multisystem proteinopathy
β˜…β˜…β˜†β˜†2025
NM_003900.5(SQSTM1):c.1231G>A (p.Gly411Ser)Pathogenic
Paget disease of bone 2, early-onset;Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|Myopathy, distal, with rimmed vacuoles|not provided|SQSTM1-related disorder|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3;Paget disease of bone 3;Myopathy, distal, with rimmed vacuoles
β˜…β˜…β˜†β˜†2025β†’ Residue 411
NM_003900.5(SQSTM1):c.286C>T (p.Arg96Ter)Pathogenic
Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset|Paget disease of bone 2, early-onset;Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
β˜…β˜…β˜†β˜†2025β†’ Residue 96
NM_003900.5(SQSTM1):c.415del (p.Arg139fs)Pathogenic
not provided|Paget disease of bone 2, early-onset;Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset
β˜…β˜…β˜†β˜†2024β†’ Residue 139
NM_003900.5(SQSTM1):c.311_312del (p.Glu104fs)Pathogenic
Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset|Neurodegeneration with ataxia
β˜…β˜…β˜†β˜†2024β†’ Residue 104
NM_003900.5(SQSTM1):c.1170del (p.Asp391fs)Pathogenic
Paget disease of bone 2, early-onset;Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 391
NM_003900.5(SQSTM1):c.1165+1G>APathogenic
Paget disease of bone 3|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset|Myopathy, distal, with rimmed vacuoles
β˜…β˜†β˜†β˜†2025
NM_003900.5(SQSTM1):c.150_157del (p.Val51fs)Pathogenic
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset
β˜…β˜†β˜†β˜†2025β†’ Residue 51
NM_003900.5(SQSTM1):c.763dup (p.Val255fs)Pathogenic
Paget disease of bone 2, early-onset;Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
β˜…β˜†β˜†β˜†2025β†’ Residue 255
NM_003900.5(SQSTM1):c.1181_*644del (p.Leu394fs)Likely pathogenic
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset
β˜…β˜†β˜†β˜†2025β†’ Residue 394
NM_003900.5(SQSTM1):c.877_899dup (p.Glu301fs)Pathogenic
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset
β˜…β˜†β˜†β˜†2025β†’ Residue 301
NM_003900.5(SQSTM1):c.838G>T (p.Glu280Ter)Pathogenic
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset
β˜…β˜†β˜†β˜†2025β†’ Residue 280
NM_003900.5(SQSTM1):c.995C>G (p.Ser332Ter)Pathogenic
Paget disease of bone 2, early-onset;Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
β˜…β˜†β˜†β˜†2025β†’ Residue 332
NM_003900.5(SQSTM1):c.1149C>G (p.Tyr383Ter)Pathogenic
Paget disease of bone 3
β˜…β˜†β˜†β˜†2025β†’ Residue 383
NM_003900.5(SQSTM1):c.46_59dup (p.Ile20fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 20
NM_003900.5(SQSTM1):c.1165G>C (p.Glu389Gln)Pathogenic
Paget disease of bone 2, early-onset;Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
β˜…β˜†β˜†β˜†2024β†’ Residue 389
NM_003900.5(SQSTM1):c.1145dup (p.Leu382fs)Likely pathogenic
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1;Paget disease of bone 2, early-onset
β˜…β˜†β˜†β˜†2024β†’ Residue 382
View on ClinVar β†—
Related Genes
BNIP3Protein interaction100%BNIP3LProtein interaction100%NIPSNAP2Protein interaction100%MAP1AProtein interaction100%MAP1BProtein interaction100%NIPSNAP1Protein interaction100%
Tissue Expression

No tissue expression data available for this gene.

Gene Interaction Network
Click a node to explore
SQSTM1BNIP3BNIP3LNIPSNAP2MAP1AMAP1BNIPSNAP1
PROTEIN STRUCTURE
Preparing viewer…
PDB6MJ7 Β· 1.41 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.13LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.86 [0.66–1.13]
RankingsWhere SQSTM1 stands among ~20K protein-coding genes
  • #145of 20,598
    Most Researched1,058 Β· top 1%
  • #1,207of 5,498
    Most Pathogenic Variants57 Β· top quartile
  • #11,676of 17,882
    Most Constrained (LOEUF)1.13
Genes detectedSQSTM1
Sources retrieved50 papers
Response timeβ€”
πŸ“„ Sources
50β–Ό
1
p62/
PMID: 30588824
Antioxid Redox Signal Β· 2019
1.00
2
p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy.
PMID: 17580304
J Biol Chem Β· 2007
0.90
3
PMID: 38124295
Autophagy Β· 2024
0.88
4
Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer.
PMID: 32859246
J Exp Clin Cancer Res Β· 2020
0.80
5
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.
PMID: 20098416
Nat Cell Biol Β· 2010
0.80